Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


22.04.2019

1 BMC Neurol
2 Diabet Med
5 Intern Med
1 J Autoimmun
2 J Immunol
2 J Neuroimmunol
3 J Pediatr
2 J Rheumatol
3 Lancet
1 Mult Scler
1 Nat Rev Neurol
1 Neurology
1 PLoS Genet
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. GAO F, Chai B, Gu C, Wu R, et al
    Effectiveness of rituximab in neuromyelitis optica: a meta-analysis.
    BMC Neurol. 2019;19:36.
    PubMed     Text format     Abstract available


    Diabet Med

  2. MCMORROW L, O' Hara MC, Hynes L, Cunningham A, et al
    The preferences of young adults with Type 1 diabetes at clinics using a discrete choice experiment approach: the D1 Now Study.
    Diabet Med. 2018 Sep 3. doi: 10.1111/dme.13809.
    PubMed     Text format     Abstract available

  3. HERRING R, Russell-Jones D
    SGLT2 inhibitors in Type 1 diabetes: is this the future?
    Diabet Med. 2018 Aug 8. doi: 10.1111/dme.13791.
    PubMed     Text format     Abstract available


    Intern Med

  4. NAGANO M, Kobayashi K, Yamada-Otani M, Kuzuya A, et al
    Hashimoto's Encephalopathy Presenting with Smoldering Limbic Encephalitis.
    Intern Med. 2019;58:1167-1172.
    PubMed     Text format     Abstract available

  5. YOROZUYA T, Ikeda K, Chiba H, Saito A, et al
    Autoimmune Pulmonary Alveolar Proteinosis Diagnosed After Exposure to a Fire Extinguisher Containing Silica Powder: A Case Study.
    Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.1557.
    PubMed     Text format     Abstract available

  6. FUJITA Y, Asano T, Sato S, Furuya MY, et al
    Coexistence of Mixed Connective Tissue Disease and Familial Mediterranean Fever in a Japanese Patient: A Case Report.
    Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2376.
    PubMed     Text format     Abstract available

  7. MATSUOKA H, Yoshida Y, Oguro E, Murata A, et al
    Diffusion Weighted Whole Body Imaging with Background Body Signal Suppression (DWIBS) Was Useful for the Diagnosis and Follow-Up of Giant Cell Arteritis.
    Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2479.
    PubMed     Text format     Abstract available

  8. SANO A, Inoue J, Kakazu E, Ninomiya M, et al
    Acute-onset Autoimmune Hepatitis in a Patient with Selective Immunoglobulin M Deficiency.
    Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2607.
    PubMed     Text format     Abstract available


    J Autoimmun

  9. BETTERIDGE Z, Tansley S, Shaddick G, Chinoy H, et al
    Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    J Autoimmun. 2019 Apr 13. pii: S0896-8411(19)30100.
    PubMed     Text format     Abstract available


    J Immunol

  10. CURRAN CS, Sommers CL, Young HA, Bourcier K, et al
    Report on the 2018 Cancer, Autoimmunity, and Immunology Conference.
    J Immunol. 2019 Apr 15. pii: jimmunol.1900264. doi: 10.4049/jimmunol.1900264.
    PubMed     Text format     Abstract available

  11. HASELMAYER P, Camps M, Liu-Bujalski L, Nguyen N, et al
    Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.
    J Immunol. 2019 Apr 15. pii: jimmunol.1800583. doi: 10.4049/jimmunol.1800583.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  12. SUN Y, Jing Y, Huang M, Ma J, et al
    The PD-1/PD-Ls pathway is up-regulated during the suppression of experimental autoimmune encephalomyelitis treated by Astragalus polysaccharides.
    J Neuroimmunol. 2019;332:78-90.
    PubMed     Text format     Abstract available

  13. KIMURA A, Takekoshi A, Yoshikura N, Hayashi Y, et al
    Clinical characteristics of autoimmune GFAP astrocytopathy.
    J Neuroimmunol. 2019;332:91-98.
    PubMed     Text format     Abstract available


    J Pediatr

  14. AESCHLIMANN FA, Chong SL, Lyons TW, Beinvogl BC, et al
    Risk of Serious Infections Associated with Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses.
    J Pediatr. 2019;204:162-171.
    PubMed     Text format     Abstract available

  15. LIOGER B, Maillot F, Ternant D, Passot C, et al
    Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    J Pediatr. 2019;204:225-233.
    PubMed     Text format     Abstract available

  16. MAGGIORE G, Nastasio S, Sciveres M
    Steroid free treatment in autoimmune hepatitis: Is azathioprine monotherapy truly a viable option to obtain remission?
    J Pediatr. 2019 Apr 11. pii: S0022-3476(19)30345.
    PubMed     Text format    


    J Rheumatol

  17. LEGGE A, Kirkland S, Rockwood K, Andreou P, et al
    Construction of a frailty index as a novel health measure in systemic lupus erythematosus.
    J Rheumatol. 2019 Apr 15. pii: jrheum.181338. doi: 10.3899/jrheum.181338.
    PubMed     Text format     Abstract available

  18. RUA-FIGUEROA I, Lopez-Longo F, Del Campo V, Galindo-Izquierdo M, et al
    Bacteremia in systemic lupus erythematosus patients from RELESSER: risk factors, clinical and microbiological characteristics and outcomes.
    J Rheumatol. 2019 Apr 15. pii: jrheum.180882. doi: 10.3899/jrheum.180882.
    PubMed     Text format     Abstract available


    Lancet

  19. RAWSHANI A, Sattar N, Franzen S, Rawshani A, et al
    Excess mortality and cardiovascular disease risk in type 1 diabetes - Authors' reply.
    Lancet. 2019;393:985-986.
    PubMed     Text format    

  20. COSTACOU T, Guo J, Miller RG, Orchard TJ, et al
    Excess mortality and cardiovascular disease risk in type 1 diabetes.
    Lancet. 2019;393:985.
    PubMed     Text format    

  21. SNAITH JR, Holmes-Walker DJ, Girgis CM, Greenfield JR, et al
    Excess mortality and cardiovascular disease risk in type 1 diabetes.
    Lancet. 2019;393:984-985.
    PubMed     Text format    


    Mult Scler

  22. PHELPS R, Winston JA, Wynn D, Habek M, et al
    Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis.
    Mult Scler. 2019 Apr 15:1352458519841829. doi: 10.1177/1352458519841829.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  23. VAUGHN CB, Jakimovski D, Kavak KS, Ramanathan M, et al
    Epidemiology and treatment of multiple sclerosis in elderly populations.
    Nat Rev Neurol. 2019 Apr 18. pii: 10.1038/s41582-019-0183.
    PubMed     Text format     Abstract available


    Neurology

  24. BRITTON JW, Dalmau J
    Recognizing autoimmune encephalitis as a cause of seizures: Treating cause and not effect.
    Neurology. 2019 Apr 12. pii: WNL.0000000000007444.
    PubMed     Text format    


    PLoS Genet

  25. HECKER M, Boxberger N, Illner N, Fitzner B, et al
    A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene.
    PLoS Genet. 2019;15:e1007961.
    PubMed     Text format     Abstract available


    PLoS One

  26. SULLIVAN CA, Cacicedo JM, Rajendran I, Steenkamp DW, et al
    Comparison of proinsulin and C-peptide secretion in healthy versus long-standing type 1 diabetes mellitus cohorts: A pilot study.
    PLoS One. 2018;13:e0207065.
    PubMed     Text format     Abstract available

  27. MAIA DINIZ I, Guerra AA Junior, Lovato Pires de Lemos L, Souza KM, et al
    The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil.
    PLoS One. 2018;13:e0199446.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: